Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term inhibitors. Found 29 abstracts

no pagination
Liu H, Sun Q, Sun Y, Zhang J, Yuan H, Pang S, Qi X, Wang H, Zhang M, Zhang H, Yu C, Gu C. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation. Molecular cancer research : MCR. 2017 Sep;15(9):1275-86.
Papadopoulos KP, Gluck L, Martin LP, Olszanski AJ, Tolcher AW, Ngarmchamnanrith G, Rasmussen E, Amore BM, Nagorsen D, Hill JS, Stephenson J. First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Oct;23(19):5703-10.
Chandramouly G, McDevitt S, Sullivan K, Kent T, Luz A, Glickman JF, Andrake M, Skorski T, Pomerantz RT. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers. Chem Biol. 2015 Nov 19;22(11):1491-504.   PMCID: PMC4701204
Najjar M, Suebsuwong C, Ray S, Thapa R, Maki J, Nogusa S, Shah S, Saleh D, Gough P, Bertin J, Yuan J, Balachandran S, Cuny G, Degterev A. Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1. Cell Reports. 2015 Mar 24;10(11):1850-60.   PMCID: 4494889
Lubet RA, Clapper ML, McCormick DL, Pereira MA, Chang WC, Steele VE, Fischer SM, Juliana MM, Grubbs CJ. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers. Oncology reports. 2012 May;27(5):1400-6.
Ratushny V, Pathak HB, Beeharry N, Tikhmyanova N, Xiao F, Li T, Litwin S, Connolly DC, Yen TJ, Weiner LM, Godwin AK, Golemis EA. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death. Oncogene. 2012 Mar 08;31(10):1217-27.   PMCID: PMC3204164
Burger RA. Overview of anti-angiogenic agents in development for ovarian cancer. Gynecologic Oncology. 2011 Apr;121(1):230-8.   PMCID: not NIH funded
Han ZY, Nogusa S, Nicolas E, Balachandran S, Taylor J. Interferon Impedes an Early Step of Hepatitis Delta Virus Infection. PLoS One. 2011 Jul;6(7):e22415.   PMCID: PMC3139649
Hensley HH, Hannoun-Levi JM, Hachem P, Mu Z, Stoyanova R, Khor LY, Agrawal S, Pollack A. PKA knockdown enhances cell killing in response to radiation and androgen deprivation. International journal of cancer. 2011 Feb 15;128(4):962-73.   PMCID: NIHMS236076
Astsaturov I, Ratushny V, Sukhanova A, Einarson MB, Bagnyukova T, Zhou Y, Devarajan K, Silverman JS, Tikhmyanova N, Skobeleva N, Pecherskaya A, Nasto RE, Sharma C, Jablonski SA, Serebriiskii IG, Weiner LM, Golemis EA. Synthetic lethal screen of an EGFR-centered network to improve targeted therapies. Science signaling. 2010 Jan;3(140):ra67.   PMCID: PMC2950064
Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl A, Herlyn M, Han M, Nakagawa H, Rustgi AK. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proceedings of the National Academy of Sciences of the United States of America. 2010 Jun;107(24):11026-31.   PMCID: PMC2890722
Kuang YH, Shen T, Chen X, Sodani K, Hopper-Borge E, Tiwari AK, Lee J, Fu LW, Chen ZS. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochemical pharmacology. 2010 Jan;79(2):154-61.   PMCID: PMC2953260
Li C, Andrake M, Dunbrack R, Enders GH. A bifunctional regulatory element in human somatic Wee1 mediates cyclin A/Cdk2 binding and Crm1-dependent nuclear export. Mol Cell Biol. 2010 Jan;30(1):116-30.   PMCID: PMC2798281
Ramirez UD, Myachina F, Stith L, Jaffe EK. Docking to large allosteric binding sites on protein surfaces. Advances in experimental medicine and biology. 2010 Jan;680:481-8.   PMCID: PMC2946403
Singh LR, Gupta S, Honig NH, Kraus JP, Kruger WD. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet. 2010 Jan;6(1):e1000807.   PMCID: PMC2795852
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Targeting EGFR resistance networks in head and neck cancer. Cellular signalling. 2009 Aug;21(8):1255-68.   PMCID: PMC2770888
Schilder RJ, Sill MW, Lee YC, Mannel R. A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2009 Jul;19(5):929-33.   PMCID: PMC2722934
Viaud J, Peterson JR. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther. 2009 Sep;8(9):2559-65.   PMCID: 2782767
Arias-Romero LE, Chernoff J. A tale of two Paks. Biol Cell. 2008 Feb;100(2):97-108.
Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW, Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL. Treatment of patients with metastatic renal cell cancer - A RAND appropriateness panel. A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Cancer. 2006 Nov;95(10):1448-53.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term inhibitors

inhibitors metabolism antagonists & genetics pharmacology Protein Kinase Inhibitors drug therapy antagonists & Female pathology Cell Line Apoptosis Mice chemistry drug effects Epidermal Growth Factor Receptor therapeutic use Protein Binding Cell Proliferation cancer Protein-Serine-Threonine Kinases RNA Interference Male Neoplasms physiology deficiency expression Treatment Outcome biosynthesis Tumor Cell Line Inbred C57BL Mice Amino Acid Sequence Drug Discovery Phosphorylation Molecular Sequence Data Middle Aged Aged Allosteric Regulation Antineoplastic Agents enzymology Mitosis Squamous Cell Carcinoma Small Interfering RNA Enzyme Inhibitors 80 and over Aged Monoclonal Antibodies angiogenesis Neoplasm Drug Resistance p21-Activated Kinases Substrate Specificity subfamily-b member-1 adverse effects Cell Nucleus genome instability Random Allocation Pyrimidines HEALTH-CARE apoptosis Single-Stranded DNA Xenograft Model Antitumor Assays tumorigenesis Fluorescence Spectrometry TRIAL immunotherapy BRCA1 Protein Drug-Related Side Effects and Adverse Reactions Pyrazines homologous recombination Multidrug resistance ABCC10 tpr-met INFORMATION HIGH-DOSE THERAPY Saccharomyces cerevisiae Porphobilinogen Synthase src-Family Kinases Macrophage Colony-Stimulating Factor lung-cancer Protein-Tyrosine Kinases Ashkenazi Cyclin-Dependent Kinase 2 topotecan Mutation Neoplastic Stem Cells Nuclear Proteins S Phase Cytoskeleton Uterine Cervical Neoplasms Enzyme Activation Molecular Docking Simulation esophageal cancer cancer-associated fibroblasts-tumor microenvironment-organotypic culture-c-met BRCA2 MUTATIONS Immunoenzyme Techniques Maximum Tolerated Dose Enzyme Stability Androgens Adult Protein Kinase C FAMILIAL BREAST Western Blotting 1993 nair anb-v382-p161 Gene Expression Profiling fibroblast-growth-factor MAP Kinase Signaling System Ovarian cancer Electrophoretic Mobility Shift Assay blood Interleukin-1 Cytotoxins toxicity Fibroblasts BONE-MARROW AUTOTRANSPLANTS OUTCOMES Molecular Models INTERLEUKIN-2 discrete choice experiment Amino Acid Motifs Preschool Child PLUS INTERFERON-ALPHA phase-ii trial Small Molecule Libraries drug-resistance system Conserved Sequence cell Cell Nucleus Active Transport BLOOD-CELL Binding Sites Gamma Rays Enhancer of Zeste Homolog 2 Protein cell lung-cancer breast cancer Pyridazines Cell Adhesion Prostatic Neoplasms Nude Mice high-throughput screening BRCA1 and BRCA2 Pyrroles Anti-angiogenic therapy G2 Phase Medulloblastoma therapy cell-proliferation Cyclin E Imidazoles synthetic lethality Karyopherins Dihydroxyphenylalanine Cultured Cells abcc10
Last updated on Thursday, April 02, 2020